DIALYSIS · CCN 492549

DaVita CDC Manassas Dialysis

MANASSAS, VA 20109

DialysisProfitDaVita
$3.7M
TOTAL REVENUE
29.4%
OPERATING MARGIN
5 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.7M
Total costs
$2.6M
Operating income (rev − costs)
$1.1M
Operating margin
29.4%
Total charges
$3.8M
Total treatments
9,380
Dialysis stations
20

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.6220—
Fistula Rate
DFC_FISTULA_RATE
81.472—
Five Star Rating
DFC_FIVE_STAR
5——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.8923—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
1——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
45.943—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.3——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
572—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
21.9181—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
14.770—
Standardized ED Visits Ratio
DFC_SEDR
1.1421—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
020—